AstraZeneca vaccine halt causes 30,000 high-risk cancellations

By | March 15, 2021

The government’s decisions to halt administering doses of the AstraZeneca vaccine has caused 30,000 high-risk individuals to have their appointments cancelled, the government confirmed today.

The Department of Health have also confirmed that they will not use the Pfizer/BioNTech or Moderna vaccines, to make up the loss caused by the suspension of the AstraZeneca vaccine.

“Of course it will be very disappointing for people not to get their jab this week, and I recognise that and regret it,” Health Minister Stephen Donnelly told the Irish Independent.

“I hope they will be comforted by the fact that the clinical advice is erring on the side of caution while this issue is investigated. I’d be glad to know that this is clinically-led.”

117,ooo people have already received their first dose of the AstraZeneca vaccine, however no person who received their first dose are scheduled to receive their second dose in the coming week.

People in the underlying health conditions group and as well as a remainder of frontline healthcare workers are still due to receive the vaccine and have has their appointments cancelled temporarily.


Deputy Chief Medical Officer Ronan Glynn made the announcement that the administration of the AstraZeneca vaccine will be temporarily deferred from this morning.

The AstraZeneca vaccine has been suspended due to recommendations made in the Norwegian Medicines Agency (NMA) that stated four people had ended up with blood clots after receiving their shots of the AstraZeneca.

The NMA also released a statement saying 22 cases of blood clotting events had been reported among the 3 million people vaccinated with the COVID-19 vaccine in the European Economic Area.

Read More:  The EU could open up a 'Pandora's box' of vaccine nationalism if it restricts exports, professor says

Other European countries have also ceased administering the AstraZeneca vaccine as a precaution, including Germany, Denmark, Iceland, Bulgaria, as well as Thailand.

Officials from France, Poland and Nigeria said they would continue using the particular vaccine shot even as national regulators investigate the problem.